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1. Introduction 
The modern world has heavily thrived on the revolution in agricultural practices that have 
culminated in tremendous boost in agricultural productivity. Pesticides are perhaps one of 
the most important and effective strategies of the green revolution. Pesticides are the only 
class of toxic substances that are intentionally released into the environment for achieving 
greater good, a decision that far outweighs their toxicological concerns.  Organophosphorus 
insecticides (OPI) are one of the most extensively used classes of insecticides. Chemically 
they are derivatives of phosphoric (H3PO4), phosphorous (H3PO3) or phosphinic acid 
(H3PO2) (Abou-Donia, 2003). The OPI were initially introduced as replacements for the 
much persistent organochlorine insecticides (Galloway & Handy, 2003). With systemic, 
contact and fumigant action, OPI find use as pest control agents in various situations. OPI 
are extensively used in agricultural practices for protecting food and commercial crops from 
various types of insects. In addition, OPI are also used in household situations for mitigating 
menacing pest varieties.  They are not very stable chemically or biochemically and are 
degraded in soil, sediments and in surface water. Perhaps, it is this instability of these 
agents that has lead to their widespread and indiscriminate use, which has exposed animal 
and human life to various forms of health hazard. The increase in their use has lead to wide 
range of ecotoxicological problems and exposure to OPI is believed to be major cause of 
morbidity and mortality in many countries.  
Huge scientific body of evidence suggests that OPI exposure is a major toxicological threat 
that may affect human and animal health because of their various toxicities such as 
neurotoxicity, endocrine toxicity, immunotoxicity, reproductive toxicity, genotoxicity and 
ability to induce organ damage, alterations in cellular oxidative balance and disrupt glucose 
homeostasis. Indeed, the data on residue levels of OPI in various sources reported from 
India does create a huge cause for concern regarding their toxic effects. Samples of raw and 
bottled water were reported to be contaminated with various OPI residues, some of which 
were much higher than recommended levels (Mathur et al., 2003). Sanghi et al. (2003) have 
reported OPI residue levels in breast milk samples in India. Based on the levels of OPI 
residues, it has been speculated that infants may consume 4.1 times higher levels of 
malathion than the average daily intake levels recommended by the World Health 
Organisation. Similarly, human blood samples were reported to be contaminated with 
residues of monocrotophos, chlorpyrifos, malathion and phosphamidon (Mathur et al., 
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2005). Thus, OPI present a realistic environmental threat that could affect various facets of 
human health.  
2. Toxicity of organophosphorus insecticides 
The toxicity of active OPI is attributed to their ability to inhibit acetylcholinesterase (AChE, 
choline hydrolase, EC 3.1.1.7), an enzyme that catalyses the hydrolysis of the 
neurotransmitter acetylcholine (ACh), leading to cholinergic stress as a result of stimulation 
of muscarinic and nicotinic ACh receptors (Fukuto, 1990; Sogorb & Vilanova, 2003; Abou-
Donia, 2003). The inhibition of AChE by an OPI takes place via a chemical reaction in which 
the serine hydroxyl moiety (of the active site) is phosphorylated. The phosphorylated 
enzyme is highly stable and, depending on the groups attached to the central ‘P’ atom of the 
OPI molecule, may be irreversibly inhibited.  
There are several factors that determine the toxicity of OPI. Important of these are route and 
levels of exposure, structure of the substance and its interaction with the 
biotransformation/detoxification system of the body. The metabolic fate of OPI is basically 
the same in insects and animals. Following absorption, the distribution of OPI is variable. 
Blood half-lives are usually short, although plasma levels are in some cases maintained for 
several days. OPI undergo extensive biotransformation, which is complex and involves 
several metabolic systems in different organs, with simultaneous oxidative 
biotransformation at a number of points in the molecule, utilizing the cytochrome P-450 
isoenzyme system. Metabolism occurs principally by oxidation, hydrolysis by esterases, and 
by transfer of portions of the molecule to glutathione.  Oxidation of OPI may result in more 
or less toxic products.   Most mammals have more efficient hydrolytic enzymes than insects 
and, therefore, are often more efficient in their detoxification processes. Numerous 
conjugation reactions follow the primary metabolic processes, and elimination of the 
phosphorus-containing residue may be via the urine or faeces. Some bound residues remain 
in exposed animals.  Binding seems to be to proteins, principally, since there are limited data 
showing that incorporation of residues into DNA (Eto, 1974). 
2.1 Neurotoxicity 
Based on structure-function relationships, OPI are essentially neurotoxicants. Most 
important of their neurotoxicities is their ‘cholinergic toxicity’, which is a consequence of 
acetylcholinesterase (AChE) inhibition by OPI leading to accumulation of ACh and 
cholinergic stress. Signs of cholinergic toxicity include miosis, muscle fasciculation, 
excessive glandular secretions, nausea and vomiting (Namba, 1971). In addition, OPI are 
known to exert two other forms of neurotoxicities- Organophosphorus ester-induced 
delayed neurotoxicity (OPIDN) and Organophosphorus ester-induced chronic neurotoxicity 
(OPICN). OPIDN is a neurodegenerative disorder characterized by delayed onset of 
prolonged ataxia and upper motor neuron spasticity as a result of single or multiple 
exposures. OPICN refers to other forms of neurotoxicity that is distinct from both 
cholinergic toxicity and OPIDN. OPICN is characterized by neuronal degeneration and 
subsequent neurobehavioral and neuropsychological consequences (Abou-Donia, 2003).  
2.2 Oxidative stress 
Numerous studies provide evidence for the propensity of OPI to disrupt oxidative balance 
leading to oxidative stress (Soltaninejad & Abdollahi, 2009). Increased lipid peroxidation, 
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protein carbonylation, depletion of cellular antioxidant pools and alterations in enzymatic 
antioxidant status appear to be chief mechanisms of OPI-induced oxidative stress that often 
results in pathophysiological changes and organ damage. Several studies have 
demonstrated usefulness of antioxidant intervention in alleviating oxidative stress and 
pathophysiological changes induced by OPI (Kamath et al., 2008, Soltaninejad & Abdollahi, 
2009). These studies lend unequivocal support to view that oxidative stress mediates as one 
of the chief mechanisms of OPI toxicity. 
3. Organophosphorus insecticides and glucose homeostasis: mechanistic 
insights 
In addition to neurotoxicity and oxidative stress, alterations in glucose homeostasis often 
culminating hyperglycemia is increasingly being reported as characteristic outcome of OPI 
toxicity. Meller et al., (1981) have described two cases of human subjects who were 
hospitalized with many complications including hyperglycemia. With no 
pseudocholinesterase detected, patients were given pralidoxime (AChE activator), which 
improved their condition and normalized hyperglycemia. Investigations revealed that they 
may have been exposed to malathion sprayed in their area. This case presents a classic case 
of hyperglycemic outcome following exposure to OPI as patients also exhibited miosis and 
muscle twitching. Numerous experiments have been conducted with experimental animals 
that reveal hyperglycemia as a characteristic outcome of OPI poisoning. A recent review by 
Rahimi & Abdollahi (2007) provides an exhaustive account of investigations revealing 
hyperglycemia in cases of OPI exposure.  
There are certain characteristic features of alterations induced by OPI in glucose 
homeostasis. In cases of exposure to single dose of OPI, hyperglycemia appears to set in 
rapidly and peak changes are often followed by a trend of normalization. High dose of 
diazinon has been reported to cause hyperglycemia in mice that follows a trend of 
normalization (Seifert, 2001). Acute exposure of rats to malathion resulted in 
hyperglycemia with peak increase occurring at 2.2h after administration followed by 
decrease after 4h (Rodrigues et al., 1986). A similar case of reversible hyperglycemia has 
been reported by Lasram et al., (2008) following administration of a single dose of 
malathion to rats.  
Biochemical changes associated with hyperglycemia serve as useful tools to understand 
etiology of OPI-induced hyperglycemia. Malathion has been reported to cause 
hyperglycemia in fasted rats. Interestingly, these hyperglycemic responses were not 
associated with hepatic glycogen depletion. The reversible phase of hyperglycemia was 
associated with increased glycogen deposition in liver, indicating that glucose may have 
come from gluconeogenesis (Gupta, 1974). Malathion induced hyperglycemia was 
associated with AChE inhibition in pancreas. More importantly, the trend of reversibility 
coincided with spontaneous reactivation of inhibited AChE (Lasram et al., 2008), 
indicating involvement of AChE-inhibition in hyperglycemia. Increase in blood glucose 
induced by sub chronic exposure of rats to malathion has been reported to be associated 
with increased glycogen phosphorylase and phosphoenolpyruvate carboxykinase 
activities, indicating involvement of both glycogenolytic and gluconeogenic processes. 
Increase in blood glucose levels induced by sub chronic exposure of rats to acephate has 
been reported to be associated with decrease in hepatic glycogen content (Deotare & 
Chakrabarti, 1981).  
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3.1 Pancreatic dysfunctions  
Acute pancreatitis is also a well known complication of OP poisoning (Dressel et al., 1979; 
Frick et al., 1987; Hsiao et al., 1996), and epidemiological findings indicate that the incidence 
of pancreatitis is high in OPI intoxication based on various pathophysiological reports 
(Gokalp et al., 2005). The precise mechanisms underlying OPI-induced pancreatitis are still 
undefined, although it is believed to involve obstruction of pancreatic ducts and /or 
enhanced reactive oxygen species (Dressel et al., 1982; Sevillano et al., 2003, Sultatos, 1994). 
Involvement of oxidative stress following acute exposure to OPI has been reported recently  
(Banerjee et al., 2001) and it has been demonstrated unequivocally that lipid peroxidation is 
one of the molecular mechanisms involved in OPI-induced cytotoxicity (Akhgari et al., 2003; 
Ranjbar et al., 2002; Abdollahi et al., 2004b).  
In view of the above, we attempted to understand the potential of repeated oral doses of 
dimethoate (DM) (at 20 and 40mg/kg b.w/d for 30days; doses corresponding to 1/20 and 
1/10LD50 values) to cause alterations in glucose homeostasis and the associated 
biochemical alterations in pancreas of rats. We observed distinct signs of glucose intolerance 
among rats administered DM (Fig. 1) at time points at which un-treated rats showed normal 
glucose tolerance after an oral glucose load (3g/kg b.w.). We also observed that DM at both 
doses caused significant increase in blood glucose levels with concomitant inhibition of 
acetylcholinesterase activity and depletion of reduced glutathione contents in pancreas 
(Table 1) (Kamath & Rajini, 2007).  
 
 
 
 
 
 
 
 
 
 
Fig. 1. Oral glucose tolerance at the end of 30 days in control (CTR) and Dimethoate (DM) 
treated rats. 
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Treatment 
 
Blood glucose (mg/dl) 
 
AChE 
(nmoles substrate 
hydrolyzed /min/mg 
protein) 
GSH 
(mg/g tissue) 
Dimethoate 
(mg/kg b.w.) 
Initial Final 
0 85.33 ± 3.85 91.33 ± 2.41 4.96 ± 1.47 1.11 ± 0.02 
20 87.34 ± 5.23 105.28 ± 3.57a 2.94 ± 1.75 0.99 ± 0.05a 
40 85.00  ± 5.30 138.67 ± 5.70,b 0.43 ± 0.21a,b 0.91 ± 0.07a,b 
Values are mean  SEM (n=6);  
a Comparison of control and other groups;  
b Comparison of DM (20mg /kg b.w.) group with DM (40 mg/kg b.w.) group  
Table 1. Blood glucose, acetylcholinesterase (AChE) and reduced glutathione (GSH) levels in 
pancreas of rats administered oral doses of Dimethoate (DM) for 30 days. 
Further, DM also caused significant pancreatic damage as reflected by increased amylase (2-
3 folds) and lipase (20 & 38%) activities in serum (Fig 2). These changes were sharply 
paralleled by significant damage in pancreatic milieu. There was a dose-related elevation in 
ROS levels in pancreas of treated rats. While the increase at the lower dose was 66%, a 
dramatic (150%) increase was evident at the higher dose. Concomitantly, a dose-related 
increase in TBARS (lipid peroxidation index) levels was observed in the pancreas of DM 
treated rats. There was 2.5 and 3.7 fold increase in TBARS level at lower and higher doses of 
DM respectively (Fig. 3). Activities of selected antioxidant enzymes were significantly 
elevated in the pancreas of treated rats compared to that of control rats. (Table 2) (Kamath & 
Rajini, 2007). These results are in accordance with the study of Hagar et al., (2002) who had 
earlier reported increased blood glucose levels and hyerinsulinemia with concomitant 
histochemical and ultramicrostructural changes in pancreas of rats following chronic 
exposure to dimethoate.  
 
 
 
Fig. 2. Changes in pancreatic damage markers in rats induced by Dimethoate after 30 days 
(DM1: 20 mg/kg b.w/d; DM2:  40 mg/kg b.w/d). Values are mean  SEM (n=6); * 
Comparison of control and other groups (P < 0.01),      Comparison of DM1 with DM2 (P < 
0.01) 
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Fig. 3. Extent of lipid peroxidation and ROS levels in pancreas of control (CTR) and 
Dimethoate treated rats (DM1: 20 mg/kg b.w/d; DM2: 40 mg/kg b.w/d). Values are mean 
 SEM (n=6); * Comparison of control and other groups (P < 0.01),      Comparison of DM1 
with DM2 (P < 0.01). 
Several studies have demonstrated pancreatitis after exposure to OPI (Dressel et al., 1979; 
Moore & James, 1988; Hsiao et al., 1996). Increase in the serum lipase and amylase activities 
reported by us clearly indicates that DM results in a state of pancreatic damage. Increased 
serum lipase activity has also been reported after administration of methidathion, an OPI 
(Mollaoglu et al., 2003). These results agree with earlier reports of acute pancreatitis in 
humans after accidental cutaneous exposure to DM (Marsh et al., 1988) and increase in 
amylase activity reported in dogs after diazinon administration (Dressel et al., 1982). 
Together, these studies clearly indicate that OPI possess propensity to elicit structural and 
functional alterations in pancreatic milieu that may be associated with disruptions in 
euglycemic conditions. From these studies, it may be argued that OPI may present a great 
threat to pancreatic functions in human beings and such threats may have far-reaching 
consequences on gluco-regulation in human beings.  
 
 
Group Enzyme Activity 
 SOD1 CAT2 GPX3 GR3 GST4 
CTR 26.42 ± 2.2 9.38 ± 0.31 27.18 ± 5.24 17.50 ± 1.60 0.03 ± 0.004 
DM1 42.72 ± 0.38a 10.24 ± 0.32 25.23 ± 3.89 19.72 ± 2.03 0.04 ± 0.003a 
DM2 56.23 ±1.18a,b 15.44 ± 0.51a,b 13.85 ± 2.20a.b 25.30 ± 1.30a,b 0.06 ± 0.003a,b 
1units/mg protein; 2µmol/min/mg protein; 3nmol/ min/ mg protein; 4µmol/ min / mg protein  
Values are mean  SEM (n=6)  
a Comparison of control (CTR) and other groups; 
b Comparison of DM1 (DM: 20mg /kg b.w/d) group with DM2 (DM: 40 mg/kg b.w/d) group 
 
Table 2. Antioxidant enzyme activities in pancreas of rats administered oral doses of 
Dimethoate for 30 days. 
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3.2 Adrenal involvement 
Studies undertaken by several researchers to investigate the mechanisms mediating 
hyperglycemic effects of OPI have mainly focused on the involvement of cholinergic stress 
and adrenal functions. We have extensively studied the mechanistic involvement of 
adrenals in glucotoxicity of OPI in rats mainly under acute and short-term exposure 
regimes. The rationale for studying adrenal involvement emerged from the typical 
hyperglycemic behaviour of single dose (oral) of two OPI-acephate and monocrotophos. 
Single dose of acephate and monocrotophos elicited rapid and transient hyperglycemia after 
administration. Both OPI were administered to overnight-fasted rats at 1/10 doses of their 
LD50 (LD50; acephate-1400mg/kg b.w., monocrotophos-18mg/kg b.w.). As depicted in Fig. 
4, both acephate and monocrotophos induced reversible hyperglycemia with peak occurring 
at 2h after exposure. Acephate induced peak hyperglycemia at 2h (87%), which tended to 
normalize thereafter and attained near-control values at 8h after administration (Joshi & 
Rajini, 2009). Similarly, monocrotophos also induced rapid hyperglycemia with peak 
occurring at 2h (103%). Interestingly, monocrotophos induced hyperglycemia exhibited 
steep reversibility compared to acephate, with normalization occurring at 6h (Joshi & Rajini, 
2010). This trend observed in the present study is consistent with other reports, which 
demonstrated reversible hyperglycemia in experimental animals following OPI 
administration. While Malathion has been reported to cause reversible hyperglycemia in 
rats (Gupta, 1974; Rodrigues et al., 1986; Seifert, 2001; Lasram et al., 2008), acute exposure to 
diazinon induced reversible hyperglycemia in mice (Seifert, 2001). 
 
 
Fig. 4. Time-course of blood glucose levels in rats administered a single oral dose of 
acephate (140mg/kg b.w.) and monocrotophos (1.8mg/kg b.w.). 
Based on the above results, we reasoned that the reversible hyperglycemia could be 
triggered by transient changes in the hormonal milieu of glucose homeostasis. Adrenals are 
an important part of the endocrine system and play a key role in glucose homeostasis by 
secreting glucocorticoid and amine hormones. Glucocorticoid hormones (GCs) (mainly 
cortisol in man and corticosterone in rodents) are secreted by the adrenal cortex under the 
control of hypothalamic-pituitary-adrenal axis. Glucocorticoid hormones, along with other 
key hormones, act to maintain blood glucose levels within narrow limits (Andrews & 
Walker, 1999). GCs, glucagon and epinephrine raise blood glucose by inhibiting glucose 
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uptake in the periphery and stimulating hepatic glucose release. Hepatic gluconeogenesis 
serves as the main source of hepatic glucose production during state of prolonged fasting 
and contributes significantly to development of diabetes mellitus (Pilkis & Granner, 1992). 
GCs facilitate gluconeogenesis as they exert permissive effect on the process by 
transcriptional activation of key enzymes of gluconeogenesis viz., glucose-6-phosphatase 
(G6Pase) (Argaud et al., 1996), phosphoenolpyruvate carboxykinase (PEPCK) (O’Brien et al., 
1990) and tyrosine aminotransferase (TAT) (Ganss et al., 1994). Increased glycogenolysis and 
gluconeogenesis appear to be the two chief mechanisms underlying OPI-induced 
hyperglycemia. Fenitrothion-induced increase in blood glucose in S. mossambicus was 
associated with decreased hepatic glycogen (Koundinya & Ramamuthi, 1979) and sub 
chronic exposure of rats to acephate, which caused slight increase in blood glucose also 
caused depletion of liver glycogen in rats (Deotare & Chakrabarthi, 1981). Abdollahi et al. 
(2004a) reported increased activity of GP and phosphoenolpyruvate carboxykinase (PEPCK) 
following sub chronic exposure to Malathion. Acute exposure to diazinon has been shown 
to cause depletion of liver glycogen with increased activity of glycogen phosphorylase, and 
also increased activities of gluconeogenesis enzymes in liver (Matin et al., 1989). Valexon is 
reported to have increased the activity of G6Pase in liver of rats (Kuz’minskaia et al., 1978). 
OPI and other AChE inhibiting organophosphate compounds exert strong influences on 
functioning of hypothalamic-pituitary-adrenal (HPA) axis, leading to increased circulating 
levels of corticosteroid hormones in vivo. This is particularly true in the case of acute 
exposure to AChE inhibiting compounds. Studies have shown elevated corticosteroid 
hormones levels in response to AChE-inhibiting compounds and role of AChE inhibition in 
the phenomenon. Single dose of Chlorfenvinphos, acephate and methamidophos have been 
demonstrated to elevate circulating levels of corticosterone and aldostserone after 
administration of a single dose (Osicka-Kaprowska et al., 1984; Spassova et al., 2000). Soman 
has been reported to increase plasma corticosterone levels in rodent models (Hudon & 
Clement, 1986; Fletcher et al., 1998). More importantly, the stressogenic potential 
(hypercorticosteronemia and induction of liver tyrosine aminotransferase activity) of soman 
was effectively abrogated by reactivators of inhibited acetylcholinesterase (Kassa, 1995 & 
1997). Similarly, stressogenic potential of Cyclohexylmethyl phosphonofluoridate (AChE 
inhibitor) has been reported to be eliminated by HI-6 (AChE reactivator) (Kassa & Bajgar, 
1995). Thus, it is clearly evident that AChE-inhibiting OPI elicit hyper stimulation of adrenal 
functions, leading to induction of gluconeogenesis enzymes in liver.      
Based on the time-course of reversible hyperglycemia induced by acephate and 
monocrotophos, further experiments were carried out to investigate the adrenal effects of 
OPI and its role in the ensuing hyperglycemia. We assessed the effects of 2 or 6h exposure to 
either acephate (oral) or 2 or 4h exposure to monocrotophos (oral) on plasma corticosterone, 
adrenal cholesterol, blood glucose, key liver gluconeogenesis enzymes (G6Pase and TAT) 
and hepatic glycogen content in rats. Interestingly, we observed that both acephate and 
monocrotophos induced strong hypercorticosteronemia with concomitant hyperglycemia 
and induction of liver gluconeogenesis enzyme activities. Further, hypercorticosteronemia 
was associated with decrease in adrenal cholesterol pools (effect of monocrotophos on 
adrenal pools described in the section on ‘comparison between single and repeated dose 
effects’), which is the precursor for corticosterone synthesis (Table 3 & 4). Depletion in 
adrenal cholesterol pools may therefore be attributable to increased synthesis and secretion 
of corticosterone. Interestingly, both OPI did not cause depletion in hepatic glycogen 
content. At time points that represented normalization of blood glucose levels, there was 
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phenomenal increase in liver glycogen levels. The data presented above clearly 
demonstrates co-existence of hypercorticosteronemia and induction of liver gluconeogenesis 
enzyme activities with hyperglycemia in OPI treated rats, indicating that OPI may trigger 
induction of liver gluconeogenesis machinery as result of hypercorticosteronemia, leading to 
hyperglycemia. 
 
 
 
At time interval after administration 
0h 2h 6h 
Plasma corticosterone * 30.9±3.4a 55.0±2.5b 44.0±2.7b 
Adrenal cholesterol** 26.5±1.4a 15.6±0.56b 12.5±0.47b 
Blood glucose *** 101.6±4.6a 182.4±5.2b 142.7±5.2c 
Liver G6Pase# 90.14±4.38a 171.93±5.61b 112.84±4.18c 
Liver TAT ## 14.28±1.34a 26.31±0.87b 23.7±0.48b 
Hepatic glycogen$ 316.2±34.90a 325.3±29.12a 1145.0±27.92b 
(Joshi and Rajini, 2009) 
Data analyzed by ANOVA followed by Tukey Test (n=6) 
*  µg/dl; ** mg/g tissue; *** mg/dl 
# glucose-6-phosphatase (nmol/min/ mg protein);  
## tyrosine aminotranferase (nmol/min/mg protein); $ µg/g tissue 
 
Table 3. Biochemical effects of acephate (140mg/kg b.w.) in rats 
 
 
 
At time interval after administration 
0h 2h 4h 
Plasma corticosterone * 36.62±1.2a 73.82±3.8b 45.65±1.8a 
Blood glucose ** 95.2±1.8a 194.8±3.7b 121.3±1.9c 
Liver TAT # 15.86±0.8a 32.27±1.2b 26.87±1.8c 
Hepatic glycogen## 213.8±49.2a 216.4±21.1a 925.7±27.6b 
(Joshi and Rajini, 2010) 
Data analyzed by ANOVA followed by Tukey Test (n=6) 
* µg/dl; ** mg/g tissue ; # tyrosine aminotranferase (nmol/min/mg protein); ## µg/g tissue 
 
Table 4. Biochemical effects of monocrotophos (1.8mg/kg b.w.) in rats 
Indeed, role of adrenals in glucotoxicity of OPI has been explored earlier. Matin et al., (1989) 
earlier demonstrated that single dose diazinon (OPI) caused hyperglycemia and induction 
of liver gluconeogenesis enzymes in normal rats while these changes did not manifest in 
adrenalectomized rats, indicating the involvement of adrenals in the glucotoxicity of 
diazinon. Our attempts to study the adrenal and glycemic effects of acephate and 
monocrotophos revealed that two compounds, which exhibit anticholinesterase property, 
elicited similar effects. Thus, the effects raised question whether the adrenal and glycemic 
effects are mediated through the anticholinesterase property of OPI. To address the 
question, we studied the extent of AChE inhibition elicited by monocrotophos at 2 and 4h 
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after administration. Influence of cholinergic antagonists was investigated at 2h after 
administration on stressogenic (hypercorticosteronemia and induction of liver TAT activity) 
and hyperglycemic potential of monocrotophos. For the purpose of mechanistic 
investigations, we employed two muscarinic cholinergic antagonists- atropine sulphate, a 
general ACh receptor antagonist that can pass through blood brain barrier (BBB) (Guarini et 
al., 2004) and methyl atropine nitrate, which is a peripherally active antagonist that does not 
pass through blood BBB (Pavlov et al., 2006). Both antagonists were administered at 
30mols/kg b.w 3-5 min before monocrotophos (1/10 LD50). 
Monocrotophos elicited significant inhibition of AChE activity (>50%) in brain, adrenals and 
liver at both 2 and 4 h after exposure (Fig. 5A). Of the organs studied, maximum inhibition 
of AChE activity was evident in brain (84 and 78% at 2 and 4 h respectively) while the 
enzyme activity in adrenals was inhibited to 32 and 34% of control activity at 2 and 4 h after 
exposure respectively. Similarly, monocrotophos administration reduced liver AChE 
activities to 47 and 46% of control at 2 and 4 h after exposure respectively. More 
importantly, we did not observe any spontaneous reactivation of inhibited AChE activity at 
4h after administration, which is an important feature of the enzymes’ behavior (Reiner and 
Aldridge, 1967; Reiner, 1971). This indicates that, while hyperglycemic potential of 
monocrotophos in rats may be a result of its anticholinesterase potency, the reversibility of 
hyperglycemia is not a consequence of spontaneous reactivation of the enzyme. 
Reversibility of hyperglycemia may hence be a consequence of counter-regulatory 
mechanism as reflected by glycogen deposition at 4h after administration. Increase in 
glycogen content upon 4h exposure is a clear indication of mobilization of glucose into 
glycogen synthesis pathway as a measure to overcome hyperglycemia. 
We also observed that both cholinergic antagonists were potent in offering protection 
against stressogenic and hyperglycemic potential of monocrotophos. Administration of 
monocrotophos elicited significant hyperglycemia (103%) (Fig. 5B). Pre- treatment of rats 
with atropine sulfate (106.04 ±1.83 compared to 191.82 ±7.59 mg/dl of monocrotophos 
alone) and atropine methyl nitrate (123.49 ±4.12 compared to 191.82 ±7.59 mg/dl of 
monocrotophos alone) offered significant protection against hyperglycemia induced by 
monocrotophos. It has been earlier demonstrated that diazinon-induced hyperglycemia 
was mediated by AChE inhibition, as revealed by protective effects of pralidoxime (AChE 
reactivator) (Seifert, 2001).  Monocrotophos-induced hypercorticosteronemia (112%) was 
effectively prevented by cholinergic antagonists (Fig. 5C). Pre-treatment of rats with 
atropine sulfate (33.98 ±2.89 compared to 76.63 ±1.76 µg/dl of monocrotophos alone) and 
atropine methyl nitrate (44.67 ±1.64 compared to 76.63 ±1.76 µg/dl of monocrotophos 
alone) offered significant protection against hypercorticosteronemia induced by 
monocrotophos. Monocrotophos induced a marked increase in the TAT activity in liver 
(107%) (Fig. 5D). Pre-treatment of rats with atropine sulfate (20.42 ±1.70 compared to 
33.38 ±1.09 nmol/min/mg protein) and atropine methyl nitrate (22.39 ±0.79 compared to 
33.38 ±1.09 nmol/min/mg protein) offered significant protection against induction of TAT 
activity. These results clearly indicated that both physiological stress 
(hypercorticosteronemia and induction of liver TAT activity) and hyperglycemia manifest 
as a consequence of peripheral muscarinic cholinergic stimulation. Corticosterone exerts 
hyperglycemic action by up-regulation of gluconeogenesis machinery. Hence, 
hypercorticosteronemia and induction of liver TAT (gluconeogenesis enzyme) activity 
accompanying hyperglycemia raises a question whether hypercorticosteronemia is 
responsible hyperglycemia in monocrotophos-treated rats.   
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Fig. 5. Protective effects of atropine (ATR) and methyl atropine (MATR) against stressogenic 
and hyperglycemic potential of monocrotophos (Mono) (Joshi and Rajini, 2010). 
Acetylcholine exerts strong influence on functioning of hypothalamus-pituitary-adrenal 
(HPA) axis. Acetylcholine has been found to increase corticotrophin releasing hormone 
(CRH) activity of hypothalamus in vitro as measured by effect on corticosteroidogenesis, an 
effect that was antagonized by atropine (Bradbury et al., 1974). ACh has also been shown to 
increase secretion of immunoreactive CRH from hypothalamus in vitro (Calogero et al., 
1988), an effect that was antagonized by ACh receptor antagonists, atropine (muscarinic) 
and hexamethonium (nicotinic). Given the importance of ACh in excitation of HPA axis, 
assessment of cholinergic stress in activation of HPA axis in monocrotophos treated rats 
becomes important. The importance of ACh in functioning of HPA axis is further 
exemplified by the fact that muscarinic receptor agonists such as carbachol (Bugajski et al., 
2002) and arecoline (Calogero et al., 1989) were found to increase ACTH and corticosterone 
in vivo. More importantly, the agonist induced increase in ACTH and corticosterone was 
antagonized by atropine (Bugajski et al., 2002), suggesting role for muscarinic ACh receptor 
in regulation of HPA axis. Role of anticholinesterase properties of organophosphate 
compounds in activation of HPA axis is demonstrated by studies showing elimination of 
stressogenic activity of cyclohexyl methyl phosphonofluoridate (as measured by plasma 
corticosterone and liver tyrosine aminotransferase activity) by HI-6, a cholinesterase 
reactivator that sufficiently reactivated inhibited AChE in brain and diaphragm (Kassa & 
Bajgar, 1995) and protection offered by atropine against diisopropylfluorophosphate 
induced increase in corticosterone levels (Smallridge et al., 1991). These studies clearly show 
the influence of ACh and involvement of muscarinic receptors in functioning of HPA axis.  
From our data on influence of cholinergic antagonists on stressogenic and hyperglycemic 
potential of monocrotophos, it could be hypothesized that muscarinic cholinergic stress 
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triggers hypercorticosteronemia, which may lead to induction of liver gluconeogenesis and 
hyperglycemia. However, experiments conducted with glucocorticoid receptor and 
adrenergic receptor antagonists revealed that hyperglycemia in mediated by adrenergic 
mechanisms while hypercorticosteronemia leads to only induction of liver TAT activity 
(data not shown). Further, we observed that monocrotophos-induced hyperglycemia was 
completely abolished by a gluconeogenesis inhibitor (data not shown). This establishes that 
physiological stress and hyperglycemia manifest in monocrotophos treated rats as 
independent consequence of peripheral cholinergic stress.  
We further compared the effects of monocrotophos on adrenal functions and glycemic 
control in rats following single and repeated doses. Comparison was made between the 
effects of a single dose (measured 2h after administration) and that of 5 or 10 doses (one 
dose per day, measured 2h after last dose). In both cases, the oral dose of 1.8mg/kg b.w. was 
employed for the purpose of comparison. Interestingly, we observed that effects single dose 
of monocrotophos on adrenal functions and glycemic control was more severe than that of 
repeated doses. Single dose of monocrotophos elicited hypercorticosteronemia (114%) with 
concomitant decrease in adrenal cholesterol (33%). These adrenal effects of single dose were 
accompanied with hyperglycemia (109%) and induction of liver tyrosine aminotransferase 
activity (113%). However, repeated administration of monocrotophos for 5 or 10days 
resulted in blunting of responses. In case of repeated exposure, increase in corticosterone 
was 76 and 67% respectively in 5 and 10d exposure groups with 18 and 13% decrease in 
adrenal cholesterol. Similarly repeated administration elicited marginal increase in blood 
glucose (39 and 32%) and induction of liver TAT activity (56 and 61%) (Fig. 6).  
 
 
Fig. 6. Adrenal and glycemic effects of monocrotophos. 
The above data clearly shows that repeated administration results in blunting of responses. 
This indicates that multiple administrations are associated with onset of some sort of 
resistance to the action of OPI. Development of tolerance to cholinesterase inhibitors during 
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multiple administrations is a well documented phenomenon (Brodeur and DuBois, 1964; 
McPhillips, 1969; Sterri et al., 1980). Tolerance to the elevation of plasma corticosterone by 
DFP was reported to develop during repeated administration (Kokka et al., 1985). Several 
studies suggest that cholinergic receptors could be involved in onset of tolerance to OPI, 
which may be mediated by events such as down regulation of muscarinic receptors (Costa et 
al., 1982a&b). Tolerance to the toxic effects of dilsulfoton during multiple exposures has 
been attributed to reduced muscarinic receptor binding in tissues of rats tolerant to the 
insecticide (Schwab et al., 1981). Blunted responses observed by us in case of repeated 
administration of monocrotophos may be attributed to tolerance mechanisms such as down 
regulation of muscarinic receptors. One mechanism that may be responsible for 
development of resistance is increased blood insulin levels. Comparison of effects of acute 
and repeated doses of monocrotophos on plasma insulin levels, however, needs to be done. 
Such a hyperinsulinemic response has been reported in case of exposure to malathion. While 
malathion caused increase in blood glucose and insulin levels after single exposure and 
continued dietary administration for 4 weeks, the degree of hyperinsulinemia was markedly 
greater in dietary group (Panahi et al., 2006). Thus, repeated administration of 
organophosphorus insecticides leads to blunting of responses. Although blunted, these 
responses still represent a great threat to euglycemic balance. This is particularly true in the 
case of constant state of hypercorticosteronemia. This has propensity to affect skeletal 
muscle glucose metabolism and long-term impairments in such mechanisms may lead to 
long lasting dysregulation in glucose homeostasis.  
3.3 OPI act as pre-disposing factors for onset of diabetes? 
Based on our comprehensive studies described above, we have proposed a scheme on the 
mechanism/s through which OPI might regulate/ disrupt glucose homeostasis (Fig. 7). 
Oxidative stress in pancreatic milieu and glucose intolerance, up regulated gluconeogenesis 
machinery and hyperglycemia are critical factors in diabetes etiology. With the ability to 
induce the above-mentioned dysregulations, OPI may have far reaching consequences on 
diabetic outcomes. This may be a more pertinent issue in the present times since diabetes is 
fast emerging as a major wide spread disorder that threatens human life. With this 
realization, our laboratory has also committed to investigate if OPI act as 
predisposing/aggravating factors for onset or progression of diabetic condition.  
We observed that dichlorvos (DDVP) treated rats showed higher (22%) levels of blood 
glucose compared to normal control rats while as expected, rats injected with the 
diabetogenic agent, Streptozotocin (STZ) alone also showed elevated (37%) level of blood 
glucose. However, blood glucose levels of DDVP pre-treated rats administered STZ 
showed relatively higher blood glucose level compared to all the groups. Liver glycogen 
levels were significantly lower in rats administered either DDVP (18%) or STZ (19%) alone 
while, rats administered DDVP followed by STZ revealed further lower levels of glycogen 
(46 %) (Table 5).  Further, we also observed that DDVP pre-treatment resulted in more 
sever oxidative stress in STZ treated rats. ROS levels were significantly elevated in STZ 
(40%) and  DDVP (55%) groups compared to ‘untreated control’ group. However, ROS 
levels were markedly higher (81.23 ± 6.52 pmole DCF/min/mg protein) in ‘DDVP+STZ’ 
group of rats. Pancreas of rats administered with either DDVP or STZ alone showed 
marginally higher levels of the lipid peroxides compared to that in ‘untreated controls’ 
while, the levels of lipid peroxides generated in pancreas of ‘DDVP+STZ’ rats showed 
www.intechopen.com
 
Insecticides – Pest Engineering 76
significant increase (110%) compared to all other groups. Pancreatic reduced glutathione 
level in ‘DDVP+STZ’ rats was significantly lower (37%) while, rats administered with 
DDVP or STZ alone also had significantly lower levels of GSH, although to a lesser extent 
(Table 6). These results clearly demonstrate that OPI act as pre-disposing factor for 
diabetes as reflected by higher degree of glucotoxicity of STZ (subdiabetogenic dose) in 
DDVP treated rats. 
 
 
Fig. 7. Proposed scheme for OPI-induced alterations in glucose homeostasis. 
Generally, an acute intraperitoneal dose of 40–60 mg/kg b.w is employed to induce 
significant hyperglycemia in rats. For the present study, we employed a lower dose of 25 
mg/kg b.w (‘sub-diabetogenic dose’) in order to examine if pre-treatment with DDVP 
renders these rats more susceptible to hyperglycemia. Experimental regime began with two 
groups with 12 rats each-control and DDVP-treated group. The DDVP-treated group 
animals were orally administered daily DDVP at 20mg/kg b.w/d (corresponding to 1/5 of 
LD50 value: 100 mg/kg b.w, determined in a preliminary study) for 10 d. After 10 days, rats 
of the control group were further divided into two sub groups of six animals each ; the first 
sub group served as control (‘untreated control’), while the second sub group of rats was 
intraperitoneally injected streptozotocin (STZ, 25 mg/kg b.w.) (‘STZ’). The group of rats 
administered with DDVP was also divided into two sub groups; the first sub group of rats 
served as DDVP control (‘DDVP’), while the second sub group of rats was injected with 
streptozotocin (i.p, 25mg/kg b.w.) (‘DDVP+STZ’). 
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Group Blood glucose1 Liver glycogen2 
CONTROL 113.53a ± 2.31 41.55c ± 2.01 
DDVP 138.37b ± 4.17 34.20b ± 1.42 
STZ 155.03c ± 5.09 33.34b ± 2.23 
DDVP+STZ 188.99d ± 4.44 22.62a ± 3.52 
1mg/dl; 2mg/g tissue; Values are mean  SEM (n=6); Mean in the same column with different 
superscript differ significantly (p<0.05) 
Table 5. Blood glucose and liver glycogen levels in rats treated with DDVP ± STZ (i.p , 25 
mg/kg b.w). 
 
Group ROS1 TBARS2 GSH3 
Untreated control 38.76a ± 4.04 242.76a ± 19.18 1.07c ± 0.03 
DDVP 60.18b ± 4.59 294.94a ± 10.65 0.83b ± 0.01 
STZ 54.27b ± 2.89 283.63a ± 7.27 0.78b ± 0.02 
DDVP+STZ 81.23c ± 6.52 389.38b ± 38.47 0.67a ± 0.02 
1pmol DCF/min/mg protein; 2nmol/g tissue; 3mg/g tissue 
Values are mean  SEM (n=6); Mean in the same column with different superscript differ significantly 
(p<0.05) 
Table 6. Oxidative stress parameters in pancreas of rats treated with DDVP ± STZ (i.p , 25 
mg/kg b.w). 
3.4 Do OPI aggravate diabetic outcomes? 
To address this question, we investigated the diabetic outcomes in rats experimentally 
rendered diabetic and post-treated with monocrotophos. Rats were rendered diabetic with 
an acute dose (60 mg/kg b.w, i.p) of streptozotocin. Monocrotophos was orally 
administered at a sublethal dose (1/20 LD50, 0.9 mg /kg b.w./d, 5 days) to both normal and 
diabetic rats. We observed that monocrotophos per se moderately increased (25%) the blood 
glucose levels in normal rats, but  significantly aggravated the hyperglycemic outcome in 
diabetic rats (56% above diabetic rats). We observed the typical lipid profile alterations 
among diabetic rats characterized by increase in total cholesterol and triglycerides (TG) in 
serum. While monocrotophos did not impact lipid profile per se, its interaction with diabetic 
component resulted in severe alterations lipid profile that reflected in phenomenal increase 
in serum triglyceride. Such augmented impairments may have high bearing on 
cardiovascular health since the cardiovascular risk index was alarmingly high among 
diabetic rats treated with monocrotophos (Fig. 8). Further, monocrotophos resulted in 
higher degree of hepatic and renal toxicity as reflected by alterations in serum transaminase 
activities and blood urea nitrogen values respectively (Table 7).  
Further, it is now established that oxidative stress in an important consequence of diabetic 
condition and plays as an important pathophysiological factor in progression of diabetic 
complications (Maritim, 2003). We observed that STZ-induced diabetes was associated with 
increased lipid peroxidation (122%), depletion of reduced glutathione (10%) and alterations 
in activities of two important antioxidant enzymes (superoxide dismutase and catalase) in 
kidney. Monocrotophos further deteriorated oxidative impairments in kidney as evidenced 
by further increase in lipid peroxidation (170%) and depletion of reduced glutathione (18%) 
content. Diabetes was associated with marginal decrease in superoxide dismutase activity in 
kidney, which was further reduced by monocrotophos treatment (35%) (Fig. 9). 
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Fig. 8. Effect of repeated oral doses of monocrotophos at 1/20 LD50 (0.9 mg/kg b.w) on 
cardiovascular index in control and diabetic rats (Begum and Rajini, 2011a). 
 Control Mono STZ STZ+Mono 
Blood  glucose 
(mg/dl) 
101.58 ±
1.4
126.91±
8.9 
382.71 ±
14.0ab
597.94 ± 
12.5cde 
TC 
(mg/dl) 
38.00 ±
2.1
41.92 ±
1.9 
50.45 ±
1.6a
50.42 ± 
1.2a 
HDL-C 
(mg/dl) 
31.09 ±
1.2
32.68 ±
1.7 
37.84 ±
1.4
35.48 ± 
1.3 
TG 
(mg/dl) 
66.74 ±
3.5
78.12 ±
6.9 
125.44 ±
9.2a
193.52 ± 
19.4bcd 
BUN 
(mg/dl) 
33.08 ±
5.6
51.88 ±
8.2 
71.18 ±
10.1a
78.05 ± 
5.2b 
SC 
(mg/dl) 
0.63 ±
0.06
0.72 ±
0.1 
0.81 ±
0.1
0.84 ± 
0.04 
Serum ALT 
(U/L) 
66.19 ±
2.0
72.24 ±
0.7 
80.03 ±
2.4
120.77 ± 
9.2abc 
Serum AST 
(U/L) 
126.57 ±
0.2
156.00 ±
18.7
199.78 ±
14.2de
341.55 ± 
8.5abc 
(Begum and Rajini, 2011a)
Data analyzed by Tukey’s HSD test; Mean  SEM (n=4) 
TC: Total cholesterol; HDL-C: High-density lipoprotein ; TG: Triglyceride; BUN: Blood Urea Nitrogen; 
SC: Serum creatinine 
Table 7. Effect of repeated oral doses of monocrotophos at 1/20 LD50 (0.9 mg/kg b.w) on 
blood glucose, lipid profile and hepatic and renal damage markers in serum in control and 
diabetic rat. 
Our work on interaction of OPI with diabetic component clearly shows that OPI can act as 
both predisposing and aggravating factors for diabetes. The inference becomes an important 
consideration to be made as the modern world is facing an escalating situation of alarming 
increase in the incidence of diabetes. Our study employed a low dose of monocrotophos, 
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which per se did not interfere with lipid profile in rats, yet causing augmentation of 
alteration in lipid profile in diabetic rats. However, other studies have clearly demonstrated 
that several OPI cause alterations in lipid profile, particularly hypertriglyceridemia 
(Ryhänen et al, 1984; Ibrahim & El-Gamal, 2003; Rezg et al., 2010). Dyslipidemia or lipid 
abnormalities play an important role in the progression of diabetes (Goldberg, 2001) and 
these are characterized by lipid derangements including hypertriglyceridemia, low high-
density cholesterol (HDL-C), and a high concentration of small dense low-density 
lipoprotein (LDL) particles. Further, a state of elevated hypertriglyceridemia is commonly 
associated with insulin resistance and represents a valuable clinical marker of the metabolic 
syndrome (Grundy et al., 1999). Propensity of OPI to induce hypertriglyceridemia coupled 
with their permissive effects of gluconeogenesis in liver creates a serious threat to glucose 
homeostasis. 
 
 
 
Fig. 9. Effect of repeated oral doses of monocrotophos at 1/20 LD50 (0.9 mg/kg b.w) on 
oxidative balance in kidney of control and diabetic rats (Begum and Rajini, 2011b). 
4. Conclusion 
Given the status of OPI as environmental pollutant with residues being detected in 
biosphere around, which are now being shown to make it into human body, it is almost 
certain that OPI will interact with etiological factors of diabetes at toxicologically significant 
levels. Interaction of living system with OPI may have severe two-way impact on glycemic 
control. As documented facilitators of hepatic glucose output via glycogenolysis and 
gluconeogenesis, OPI are most likely to elicit hyperglycaemic responses in humans during 
exposure. Further, OPI may also affect the responsiveness to human system to insulin via 
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multiple mechanisms, causing predisposition to diabetes. From our studies, it is also clear 
that OPI may also act to augment diabetic outcomes. In most societies, large sections of 
populations are subject to diabetes risk factors such as unhealthy diet patterns, lack of 
physical exercise and obesity.  With such high odds of risk factors, the burden of constant 
exposure to OPI (as environmental pollutants) could be a silent aggravating factor that is 
causing increase in incidence of diabetes. 
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